NeuroMetrix Company Overview
About NeuroMetrix
NeuroMetrix (NASDAQ:NURO) specializes in the development and commercialization of healthcare devices and technologies aimed at treating chronic pain, sleep disorders, and diabetes. This innovative company focuses on creating products that improve patients' quality of life by leveraging state-of-the-art neurological diagnostics and therapeutic technologies. Among its portfolio, the Quell Wearable Pain Relief Technology stands out as a flagship product, demonstrating NeuroMetrix's commitment to non-invasive solutions for chronic pain management. With a clear objective to enhance patient outcomes through groundbreaking healthcare solutions, NeuroMetrix continues to invest in research and development to expand its product offerings and impact in the healthcare industry.
Snapshot
Operations
Products and/or services of NeuroMetrix
- Quell Wearable Pain Relief Technology - A wearable device providing 100% drug-free, over-the-counter pain relief through advanced neurostimulation.
- DPNCheck - A portable device designed for the rapid, quantitative assessment of peripheral neuropathies, specifically diabetic peripheral neuropathy (DPN).
- ADVANCE System - A platform developed for the performance of nerve conduction studies (NCS) aimed at diagnosing various neuromuscular disorders.
- Sensus Device - A convenient, non-invasive device intended for managing chronic pain, particularly in the leg and foot areas.
- NC-stat DPNCheck - An enhanced version of DPNCheck, targeting broader applications in the detection and management of neuropathies.
- Quell App - An accompanying app for the Quell technology that tracks sleep, therapy, and pain levels, allowing users to customize their pain management.
NeuroMetrix executive team
- Dr. Shai N. Gozani M.D., Ph.D.Founder, Chairman, CEO, President & Secretary
- Mr. Thomas T. HigginsSenior VP, CFO & Treasurer
- Ms. Susan M. Bell R.N.Senior Vice President of Population Health & Value Based Care